CN110559438B - 一种核磁共振成像引导的光热和光动诊疗一体化试剂及其制备方法 - Google Patents
一种核磁共振成像引导的光热和光动诊疗一体化试剂及其制备方法 Download PDFInfo
- Publication number
- CN110559438B CN110559438B CN201910742710.4A CN201910742710A CN110559438B CN 110559438 B CN110559438 B CN 110559438B CN 201910742710 A CN201910742710 A CN 201910742710A CN 110559438 B CN110559438 B CN 110559438B
- Authority
- CN
- China
- Prior art keywords
- solution
- photothermal
- preparation
- magnetic resonance
- resonance imaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910742710.4A CN110559438B (zh) | 2019-08-13 | 2019-08-13 | 一种核磁共振成像引导的光热和光动诊疗一体化试剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910742710.4A CN110559438B (zh) | 2019-08-13 | 2019-08-13 | 一种核磁共振成像引导的光热和光动诊疗一体化试剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110559438A CN110559438A (zh) | 2019-12-13 |
CN110559438B true CN110559438B (zh) | 2021-10-01 |
Family
ID=68775152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910742710.4A Active CN110559438B (zh) | 2019-08-13 | 2019-08-13 | 一种核磁共振成像引导的光热和光动诊疗一体化试剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110559438B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113735886B (zh) * | 2020-05-13 | 2022-06-03 | 北京大学 | Pdt化合物及其制备方法和用途 |
CN113679837A (zh) * | 2021-08-17 | 2021-11-23 | 南京工业大学 | 一种窄带隙无机纳米酶治疗试剂及其制备方法与应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9474769B2 (en) * | 2008-02-08 | 2016-10-25 | Yeu-Kuang Hwu | Methods of treating cancers |
CN107441507B (zh) * | 2017-07-26 | 2020-05-15 | 苏州大学 | 由肿瘤细胞激活的诊疗一体化纳米探针及其应用 |
CN109010828B (zh) * | 2018-10-12 | 2020-10-20 | 中国科学院高能物理研究所 | 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途 |
-
2019
- 2019-08-13 CN CN201910742710.4A patent/CN110559438B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN110559438A (zh) | 2019-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dong et al. | Upconversion-mediated ZnFe 2 O 4 nanoplatform for NIR-enhanced chemodynamic and photodynamic therapy | |
Yuan et al. | In situ-transition nanozyme triggered by tumor microenvironment boosts synergistic cancer radio-/chemotherapy through disrupting redox homeostasis | |
CN108578716B (zh) | 一种聚多巴胺包裹的磁性介孔二氧化硅纳米材料及其制备和应用 | |
Liu et al. | A smart theranostic agent based on Fe-HPPy@ Au/DOX for CT imaging and PTT/chemotherapy/CDT combined anticancer therapy | |
Wang et al. | Retracted Article: A tumor-microenvironment fully responsive nano-platform for MRI-guided photodynamic and photothermal synergistic therapy | |
Croissant et al. | Multifunctional gold-mesoporous silica nanocomposites for enhanced two-photon imaging and therapy of cancer cells | |
CN110559438B (zh) | 一种核磁共振成像引导的光热和光动诊疗一体化试剂及其制备方法 | |
CN108836949B (zh) | Ce6嵌入型红细胞膜包裹普鲁士蓝纳米颗粒的制备方法 | |
Cai et al. | Polypyrrole-coated UCNPs@ mSiO 2@ ZnO nanocomposite for combined photodynamic and photothermal therapy | |
CN110038128B (zh) | 一种Au@Se@Pt-Ce6纳米复合探针及其制备方法 | |
CN112143499B (zh) | 一种诊疗一体化的稀土发光纳米诊疗剂、制备方法及其应用 | |
Liu et al. | X-ray and NIR light dual-triggered mesoporous upconversion nanophosphor/Bi heterojunction radiosensitizer for highly efficient tumor ablation | |
Chu et al. | NIR Responsive Doxorubicin‐Loaded Hollow Copper Ferrite@ Polydopamine for Synergistic Chemodynamic/Photothermal/Chemo‐Therapy | |
Wang et al. | Ultra-high payload of doxorubicin and pH-responsive drug release in CuS nanocages for a combination of chemotherapy and photothermal therapy | |
CN108969766B (zh) | 具有肿瘤微环境响应增氧性能的光敏复合材料及制备方法 | |
CN111603559B (zh) | 铜碘簇化合物@光敏剂复合纳米颗粒及其作为x射线光动力治疗药物的应用 | |
Gao et al. | 3D CNT/MXene microspheres for combined photothermal/photodynamic/chemo for cancer treatment | |
Li et al. | A synergistic chemodynamic–photodynamic-photothermal therapy platform based on biodegradable Ce-doped MoO x nanoparticles | |
Zhang et al. | Tumor Microenvironment‐Responsive Nanocarrier Based on VOx Nanozyme Amplify Oxidative Stress for Tumor Therapy | |
Chu et al. | Manganese Amplifies Photoinduced ROS in Toluidine Blue Carbon Dots to Boost MRI Guided Chemo/Photodynamic Therapy | |
Zhang et al. | Synergistic therapeutic effect of nanomotors triggered by Near-infrared light and acidic conditions of tumor | |
CN117482231A (zh) | 一种应用于肿瘤免疫治疗的多孔铜锰双金属纳米材料及其制备方法 | |
Pan et al. | Self-assembled quercetin-Fe3+ nanoparticles for synergetic near-infrared light-triggered low-temperature photothermal/glutathione-activated chemodynamic therapy | |
CN110946999B (zh) | 一种诊疗一体化纳米平台、制备方法及其应用 | |
CN114949186A (zh) | 一种pod-god协同改性的介孔硅纳米材料、制备方法及用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20191213 Assignee: Kunming Junxiang Pharmaceutical Technology Co.,Ltd. Assignor: Hubei University Contract record no.: X2023530000013 Denomination of invention: A nuclear magnetic resonance imaging guided photothermal and photodynamic diagnostic and therapeutic integrated reagent and its preparation method Granted publication date: 20211001 License type: Common License Record date: 20230403 Application publication date: 20191213 Assignee: Yunnan Benyi Biotechnology Co.,Ltd. Assignor: Hubei University Contract record no.: X2023530000011 Denomination of invention: A nuclear magnetic resonance imaging guided photothermal and photodynamic diagnostic and therapeutic integrated reagent and its preparation method Granted publication date: 20211001 License type: Common License Record date: 20230403 Application publication date: 20191213 Assignee: Kunming Daren Medical Equipment Co.,Ltd. Assignor: Hubei University Contract record no.: X2023530000012 Denomination of invention: A nuclear magnetic resonance imaging guided photothermal and photodynamic diagnostic and therapeutic integrated reagent and its preparation method Granted publication date: 20211001 License type: Common License Record date: 20230403 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20191213 Assignee: Weimi Medical (Yunnan) Co.,Ltd. Assignor: Hubei University Contract record no.: X2023980040027 Denomination of invention: A nuclear magnetic resonance imaging guided photothermal and photodynamic diagnostic and therapeutic integrated reagent and its preparation method Granted publication date: 20211001 License type: Common License Record date: 20230822 |
|
EE01 | Entry into force of recordation of patent licensing contract |